Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group

doi:10.1016/S2213-2600(23)00147-9

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	791-803
Number of pages	13
Journal	The Lancet Respiratory Medicine
Volume	11
Issue number	9
DOIs	https://doi.org/10.1016/S2213-2600(23)00147-9
State	Published - Sep 2023

ASJC Scopus Subject Areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/S2213-2600(23)00147-9

OpenUrl availability

Full text

Cite this

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial. / ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group.
In: The Lancet Respiratory Medicine, Vol. 11, No. 9, 09.2023, p. 791-803.

Research output: Contribution to journal › Article › peer-review

@article{988fb282b8254ba58b5aa8b71922d65f,

title = "Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial",

author = "{ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group} and Brown, {Samuel M.} and Barkauskas, {Christina E.} and Birgit Grund and Shweta Sharma and Phillips, {Andrew N.} and Lindsay Leither and Peltan, {Ithan D.} and Michael Lanspa and Gilstrap, {Daniel L.} and Ahmad Mourad and Kathleen Lane and Beitler, {Jeremy R.} and Serra, {Alexis L.} and Ivan Garcia and Eyad Almasri and Mohamed Fayed and Kinsley Hubel and Harris, {Estelle S.} and Middleton, {Elizabeth A.} and Barrios, {Macy A.G.} and Mathews, {Kusum S.} and Goel, {Neha N.} and Samuel Acquah and Jarrod Mosier and Cameron Hypes and {Salvagio Campbell}, Elizabeth and Akram Khan and Hough, {Catherine L.} and Wilson, {Jennifer G.} and Levitt, {Joseph E.} and Abhijit Duggal and Siddharth Dugar and Goodwin, {Andrew J.} and Charles Terry and Peter Chen and Sam Torbati and Nithya Iyer and Sandkovsky, {Uriel S.} and Johnson, {Nicholas J.} and Robinson, {Bryce R.H.} and Matthay, {Michael A.} and Aggarwal, {Neil R.} and Douglas, {Ivor S.} and Casey, {Jonathan D.} and Manuel Hache-Marliere and {Georges Youssef}, J. and William Nkemdirim and Brad Leshnower and Omar Awan and Anholm, {James D.}",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Ltd",

year = "2023",

month = sep,

doi = "10.1016/S2213-2600(23)00147-9",

language = "English",

volume = "11",

pages = "791--803",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

number = "9",

}

TY - JOUR

T1 - Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO)

T2 - a randomised, placebo-controlled trial

AU - ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group

AU - Brown, Samuel M.

AU - Barkauskas, Christina E.

AU - Grund, Birgit

AU - Sharma, Shweta

AU - Phillips, Andrew N.

AU - Leither, Lindsay

AU - Peltan, Ithan D.

AU - Lanspa, Michael

AU - Gilstrap, Daniel L.

AU - Mourad, Ahmad

AU - Lane, Kathleen

AU - Beitler, Jeremy R.

AU - Serra, Alexis L.

AU - Garcia, Ivan

AU - Almasri, Eyad

AU - Fayed, Mohamed

AU - Hubel, Kinsley

AU - Harris, Estelle S.

AU - Middleton, Elizabeth A.

AU - Barrios, Macy A.G.

AU - Mathews, Kusum S.

AU - Goel, Neha N.

AU - Acquah, Samuel

AU - Mosier, Jarrod

AU - Hypes, Cameron

AU - Salvagio Campbell, Elizabeth

AU - Khan, Akram

AU - Hough, Catherine L.

AU - Wilson, Jennifer G.

AU - Levitt, Joseph E.

AU - Duggal, Abhijit

AU - Dugar, Siddharth

AU - Goodwin, Andrew J.

AU - Terry, Charles

AU - Chen, Peter

AU - Torbati, Sam

AU - Iyer, Nithya

AU - Sandkovsky, Uriel S.

AU - Johnson, Nicholas J.

AU - Robinson, Bryce R.H.

AU - Matthay, Michael A.

AU - Aggarwal, Neil R.

AU - Douglas, Ivor S.

AU - Casey, Jonathan D.

AU - Hache-Marliere, Manuel

AU - Georges Youssef, J.

AU - Nkemdirim, William

AU - Leshnower, Brad

AU - Awan, Omar

AU - Anholm, James D.

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85169037378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85169037378&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(23)00147-9

DO - 10.1016/S2213-2600(23)00147-9

M3 - Article

C2 - 37348524

AN - SCOPUS:85169037378

SN - 2213-2600

VL - 11

SP - 791

EP - 803

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 9

ER -

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this